You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 27 No. 4, October 1972 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL ARTICLES
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal

Chlorpromazine in Chronic Schizophrenia

The Effect of Age and Hospitalization on Behavioral Dose-Response Relationships

Mervin L. Clark, MD; H. Rudy Ramsey, PhD; Don K. Rahhal, MD; Eustace A. Serafetinides, MD, PhD; Fredda D. Wood; J. Paul Costiloe, MS

Arch Gen Psychiatry. 1972;27(4):479-483.


Abstract

Behavioral data from a previous study were stratified by age (< 40 or > 40 years) and duration of hospitalization (< 10 or > 10 years) and examined for dose-response relationships at the 12th week of treatment with either placebo or 150, 300, or 600 mg chlorpromazine per day.

It was found that the shorter hospitalized patients (< 10 years) and to a lesser extent, the younger patients (< 40 years) as well, responded better to the higher dose (600 mg/day) whereas the longer hospitalized patients (> 10 years) and older patients ( ≥ 40 years) achieved no improvement in response beyond 300 mg/day.



Author Affiliations

Oklahoma City

From the Division of Clinical Pharmacology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, and Central State Griffin Memorial Hospital, Norman, Okla (Dr. Clark); the Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City (Dr. Serafetinides): and the Division of Clinical Pharmacology, Department of Medicine, University of Oklahoma Health Sciences Center (Drs. Ramsey, Rahhal, Wood, and Costiloe).


Footnotes

Accepted for publication April 6, 1972.

Reprint requests to the University of Oklahoma Health Sciences Center, 800 NE 13th St, Oklahoma City 73104 (Dr. Clark).



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

'Akinetic Depression' in Schizophrenia
Van Putten and May
Arch Gen Psychiatry 1978;35:1101-1107.
ABSTRACT  

Very High Dose Fluphenazine Decanoate: A Controlled Trial in Chronic Schizophrenia
McClelland et al.
Arch Gen Psychiatry 1976;33:1435-1439.
ABSTRACT  

Amitriptyline-Perphenazine Interaction in Ambulatory Schizophrenic Patients: A Controlled Study of Drug Interaction
Chouinard et al.
Arch Gen Psychiatry 1975;32:1295-1307.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1972 American Medical Association. All Rights Reserved.